Birdwatch Note
2024-05-30 08:56:11 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
医科学的には下記のように無数の研究が接種とコロナ後遺症に関してなされており、それらがされてないような話は客観的に事実ではありません。 コロナ感染後後遺症のリスクが接種者が大きいかは国内外で無数の研究がされオミクロンの前は勿論、オミクロン流行期期に絞っても2回接種者ですら3割程未接種者よりリスクが低かった事がメタ解析レベルで報告されています 以下のメタ解析の https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/effectiveness-of-covid19-vaccine-in-the-prevention-of-postcovid-conditions-a-systematic-literature-review-and-metaanalysis-of-the-latest-research/A0B115B5D3AA60846799857B801D116E 以下の有効性31.8%の結果です https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20231013000915907-0717:S2732494X23004473:S2732494X23004473_tab2.png?pub-status=live 厚生労働省の研究班の19万人の住民の調査でも感染前にワクチンを接種した人は接種していない人に比べて症状が続く割合がやや低かった事が発表されています↓ https://www3.nhk.or.jp/news/html/20230923/k10014204451000.html
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1796014491001385028
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1796103299516743903
- noteId - 1796103299516743903
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1717059371247
- tweetId - 1796014491001385028
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 医科学的には下記のように無数の研究が接種とコロナ後遺症に関してなされており、それらがされてないような話は客観的に事実ではありません。 コロナ感染後後遺症のリスクが接種者が大きいかは国内外で無数の研究がされオミクロンの前は勿論、オミクロン流行期期に絞っても2回接種者ですら3割程未接種者よりリスクが低かった事がメタ解析レベルで報告されています 以下のメタ解析の https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/effectiveness-of-covid19-vaccine-in-the-prevention-of-postcovid-conditions-a-systematic-literature-review-and-metaanalysis-of-the-latest-research/A0B115B5D3AA60846799857B801D116E 以下の有効性31.8%の結果です https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20231013000915907-0717:S2732494X23004473:S2732494X23004473_tab2.png?pub-status=live 厚生労働省の研究班の19万人の住民の調査でも感染前にワクチンを接種した人は接種していない人に比べて症状が続く割合がやや低かった事が発表されています↓ https://www3.nhk.or.jp/news/html/20230923/k10014204451000.html
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-05-30 08:56:11 UTC (1717059371247) |
2024-05-30 15:41:16 UTC (1717083676334) |
CURRENTLY_RATED_HELPFUL | 2024-05-31 03:25:54 UTC (1717125954731) |
NEEDS_MORE_RATINGS | 2024-05-30 15:41:16 UTC (1717083676334) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-05-30 10:54:26 -0500 | Rating Details | |
2024-05-30 09:08:53 -0500 | Rating Details | |
2024-05-30 08:40:24 -0500 | Rating Details | |
2024-05-30 08:32:02 -0500 | Rating Details | |
2024-05-30 08:18:56 -0500 | Rating Details | |
2024-05-30 07:58:35 -0500 | Rating Details | |
2024-05-30 07:55:01 -0500 | Rating Details | |
2024-05-30 07:46:03 -0500 | Rating Details | |
2024-05-30 07:05:56 -0500 | Rating Details | |
2024-05-30 06:44:49 -0500 | Rating Details | |
2024-05-30 06:34:43 -0500 | Rating Details | |
2024-05-30 06:14:43 -0500 | Rating Details | |
2024-05-30 05:54:53 -0500 | Rating Details | |
2024-05-30 05:43:52 -0500 | Rating Details | |
2024-05-30 05:36:51 -0500 | Rating Details | |
2024-05-30 05:24:48 -0500 | Rating Details | |
2024-05-30 04:56:19 -0500 | Rating Details | |
2024-05-30 04:50:42 -0500 | Rating Details | |
2024-05-30 04:50:10 -0500 | Rating Details | |
2024-05-30 04:47:33 -0500 | Rating Details | |
2024-05-30 04:45:30 -0500 | Rating Details | |
2024-05-30 04:27:59 -0500 | Rating Details | |
2024-05-30 04:05:35 -0500 | Rating Details | |
2024-05-31 19:21:14 -0500 | Rating Details | |
2024-05-31 09:49:50 -0500 | Rating Details | |
2024-05-31 04:54:00 -0500 | Rating Details | |
2024-05-30 16:06:00 -0500 | Rating Details | |
2024-05-30 09:44:20 -0500 | Rating Details | |
2024-05-30 09:33:22 -0500 | Rating Details | |
2024-05-30 08:48:48 -0500 | Rating Details | |
2024-05-30 07:43:52 -0500 | Rating Details | |
2024-05-30 07:15:11 -0500 | Rating Details | |
2024-05-30 06:49:46 -0500 | Rating Details | |
2024-05-30 06:48:32 -0500 | Rating Details | |
2024-05-30 05:22:10 -0500 | Rating Details | |
2024-05-30 04:55:58 -0500 | Rating Details | |
2024-05-30 04:52:48 -0500 | Rating Details | |
2024-05-30 04:49:20 -0500 | Rating Details | |
2024-05-30 04:47:51 -0500 | Rating Details | |
2024-05-30 04:47:13 -0500 | Rating Details | |
2024-05-30 04:47:07 -0500 | Rating Details | |
2024-05-30 04:43:10 -0500 | Rating Details | |
2024-05-30 04:42:54 -0500 | Rating Details | |
2024-05-30 04:31:52 -0500 | Rating Details | |
2024-05-30 04:26:37 -0500 | Rating Details | |
2024-05-30 04:11:45 -0500 | Rating Details | |
2024-05-30 03:59:23 -0500 | Rating Details | |
2024-05-30 03:58:30 -0500 | Rating Details | |
2024-06-01 08:29:57 -0500 | Rating Details | |
2024-05-30 19:49:23 -0500 | Rating Details | |
2024-05-30 09:37:53 -0500 | Rating Details | |
2024-05-30 08:51:17 -0500 | Rating Details | |
2024-05-30 07:47:21 -0500 | Rating Details | |
2024-05-30 06:28:01 -0500 | Rating Details | |
2024-05-30 05:36:10 -0500 | Rating Details | |
2024-05-30 05:33:01 -0500 | Rating Details | |
2024-05-30 05:23:00 -0500 | Rating Details | |
2024-05-30 05:18:49 -0500 | Rating Details | |
2024-05-30 05:09:26 -0500 | Rating Details | |
2024-05-30 05:09:18 -0500 | Rating Details | |
2024-05-30 05:05:26 -0500 | Rating Details | |
2024-05-30 05:04:26 -0500 | Rating Details | |
2024-05-30 05:03:02 -0500 | Rating Details | |
2024-05-30 04:41:49 -0500 | Rating Details | |
2024-05-30 04:41:24 -0500 | Rating Details | |
2024-05-30 04:40:12 -0500 | Rating Details | |
2024-05-30 04:38:17 -0500 | Rating Details | |
2024-05-30 04:26:28 -0500 | Rating Details | |
2024-05-30 04:24:41 -0500 | Rating Details | |
2024-05-30 04:22:42 -0500 | Rating Details | |
2024-05-30 04:17:34 -0500 | Rating Details | |
2024-05-30 04:07:57 -0500 | Rating Details | |
2024-06-09 09:41:00 -0500 | Rating Details | |
2024-05-31 18:23:04 -0500 | Rating Details |